Povidone-iodine functionalized nanofibers are prophylactic and protect against dissemination of SARS-CoV-2 infection.
E AmlerV VojáčekBruno SopkoRadek DivinAleksei PashchenkoJ VargaA NečasV CelerZ FilipejovaL UrbanováJ RulcM KrajníkováT JarošíkováPublished in: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne (2024)
The novel personal protection equipment based on a face mask equipped with a nanofiber filter functionalized with povidone iodine has been developed and tested in a clinical trial. This nanofiber filter was characterized with a low flow resistance and, thus, allowed comfortable breathing. The performed study proved that the novel nanofiber filter with incorporated povidone-iodine was characterized with a slow release of iodine which minimized side effects but kept disinfection efficiency. Our clinical study performed on 207 positively tested SARS-CoV-2 patients wearing the PPE for 4-8 hours daily for 1 to 4 days has shown that even the iodine amount as low as 0.00028 ppm was sufficient to significantly decrease the reproduction number and, very importantly, to protect against severe course of disease.
Keyphrases
- dual energy
- sars cov
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- quantum dots
- computed tomography
- chronic kidney disease
- respiratory syndrome coronavirus
- physical activity
- prognostic factors
- randomized controlled trial
- drinking water
- early onset
- double blind
- magnetic resonance
- open label
- phase ii
- mass spectrometry
- obstructive sleep apnea